<p>Adverse events of COVID-19 vaccine by current treatment status.</p>

NIAID Data Ecosystem2026-05-10 收录

数据链接：

https://figshare.com/articles/dataset/_p_Adverse_events_of_COVID-19_vaccine_by_current_treatment_status_p_/31433010 数据链接链接失效反馈

官方服务：

资源简介：

Adverse events of COVID-19 vaccine by current treatment status.

创建时间：

2026-02-27

粤北第二人民医院近三年不良事件明细数据集

不良事件分析

患者安全风险管理

本数据集源自粤北第二人民医院不良事件管理记录数据，涵盖了患者事件发生详情、后续处理措施等多维度信息。该数据集包含了 274 条不良事件信息记录，涉及涵盖性别、发生时间、发生时病人活动状态等多方面内容。数据经标准化整理后形成结构化数据集，可用于医疗安全风险评估、不良事件归因分析、护理质量改进等场景。

广东省数据知识产权存证登记平台2026-01-08 更新160

Adverse events in patients taking macrolide antibiotics versus placebo for any indication: Supplementary data set B

用药安全

不良事件分析

Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.

Research Data Australia80

Baseline characteristics of the patients with and without adverse events.

心血管疾病

不良事件分析

ADMA = asymmetric dimethylarginine; AF = atrial fibrillation; CAD = coronary artery disease; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention; TIA = tran

NIAID Data Ecosystem60

Grade 3 or 4 clinical events or laboratory abnormalities.

临床试验安全监测

不良事件分析

Grade 3 or 4 clinical events or laboratory abnormalities.

NIAID Data Ecosystem150

Additional file 4 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

肿瘤治疗安全性

不良事件分析

Additional file 4. Adverse Events.

DataCite Commons2024-02-08 更新80